Should You Buy Horizon Therapeutics PLC (HZNP) in Drug Manufacturers - General Industry?
Monday, April 25, 2022 06:36 AM | InvestorsObserver Analysts
Mentioned in this article
Horizon Therapeutics PLC (HZNP) is the highest overall rated company in the Drug Manufacturers - General industry with an overall score of 78. HZNP is up 10.85% so far this year after the company closed yesterday at $105.84. The overall score measures the company's performance based-off both short and long term indicators and means that HZNP scores better than 78% of the overall market.
HZNP has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on HZNP!
Horizon Therapeutics PLC is a strong performer in the Drug Manufacturers - General industry, which has an average overall score of 56. This means that, on average, the stocks in this industry score higher than 56% of the stock market.
